Skip to main content
logo
CHO Pharma, Inc. (TPEX:6586)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
115.50
-2.50 (-2.12%)
Aug 6, 2026, 9:08 AM CST

CHO Pharma Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.431.433.58-0.063.57
Revenue Growth
-55.42%-60.03%---98.32%2486.96%
Gross Profit
1.071.071.71-0.063.36
Operating Income
-325.84-325.84-249.29-269-350.9-210.49
Net Income
-290.01-290.01-212.23-306.09-338.39-205.93
Earnings Per Share
-1.36-1.36-0.99-1.60-1.84-1.12
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,0602,0602,3662,6031,0451,317
Total Debt
14.5914.5928.9-11.725.56
Net Cash (Debt)
2,0462,0462,3372,6031,0331,291
Net Cash Growth
-7.24%-12.47%-10.21%151.99%-20.02%-13.16%
Net Cash Per Share
9.569.5610.9213.605.617.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-279.57-279.57-217.38-291.13-249.5-193.47
Capital Expenditures
-9.3-9.3-5.49-2-9.4-2.64
Free Cash Flow
-288.87-288.87-222.87-293.13-258.9-196.11
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
74.49%74.49%47.77%-98.33%94.09%
Operating Margin
-22770.16%-22770.16%-6963.49%--584833.33%-5896.11%
Pretax Margin
-20265.97%-20265.97%-5928.10%--563988.33%-5768.21%
Profit Margin
-20265.97%-20265.97%-5928.10%--563988.33%-5768.21%
FCF Margin
-20186.58%-20186.58%-6225.53%--431501.67%-5493.25%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17647.274202.443078.64-420067.124300.98